Stay updated on ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial
Sign up to get notified when there's something new on the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page.

Latest updates to the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page
- Check6 days agoChange DetectedThe history now shows an added Revision: v3.3.2 and a deleted Revision: v3.3.1 for the page.SummaryDifference0.0%

- Check13 days agoChange DetectedThe record history now shows a new Revision: v3.3.1 and removes Revision: v3.2.0. This appears to be an administrative update to the site's revision labeling.SummaryDifference0.0%

- Check20 days agoChange DetectedRemoved the banner about government funding delays and current operating status from the page header. This change affects only the UI notice and does not alter the trial data.SummaryDifference0.3%

- Check34 days agoChange DetectedA new Study Status entry was added on 2025-10-27, with version 85 documented on 2025-10-24. A prior entry from 2025-08-01 was deleted.SummaryDifference0.2%

- Check63 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference8%

- Check70 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.2%

Stay in the know with updates to ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page.